Judith Hackett

429 total citations
16 papers, 248 citations indexed

About

Judith Hackett is a scholar working on Epidemiology, Infectious Diseases and Economics and Econometrics. According to data from OpenAlex, Judith Hackett has authored 16 papers receiving a total of 248 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 4 papers in Infectious Diseases and 3 papers in Economics and Econometrics. Recurrent topics in Judith Hackett's work include Respiratory viral infections research (8 papers), Influenza Virus Research Studies (6 papers) and Pneumonia and Respiratory Infections (4 papers). Judith Hackett is often cited by papers focused on Respiratory viral infections research (8 papers), Influenza Virus Research Studies (6 papers) and Pneumonia and Respiratory Infections (4 papers). Judith Hackett collaborates with scholars based in United States, United Kingdom and Switzerland. Judith Hackett's co-authors include Xiaohui Jiang, Jon P. Fryzek, Tonya Villafana, Jenna E. Coalson, Christopher S. Ambrose, Stephan Harbarth, Gerhild Angyalosi, Anne Witschi, Evelina Tacconelli and Seamus O’Brien and has published in prestigious journals such as PLoS ONE, Journal of Antimicrobial Chemotherapy and Alzheimer s & Dementia.

In The Last Decade

Judith Hackett

15 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith Hackett United States 7 138 56 50 41 32 16 248
Falitsa Mandraka Germany 9 205 1.5× 29 0.5× 67 1.3× 22 0.5× 19 0.6× 15 291
Mercedes Palomar Martínez Spain 9 87 0.6× 63 1.1× 36 0.7× 20 0.5× 53 1.7× 31 230
Laura Campogiani Italy 9 69 0.5× 95 1.7× 42 0.8× 17 0.4× 24 0.8× 32 222
Federica Calò Italy 10 77 0.6× 80 1.4× 36 0.7× 19 0.5× 42 1.3× 21 242
Dennis Souverein Netherlands 9 84 0.6× 82 1.5× 59 1.2× 22 0.5× 23 0.7× 18 231
Sonia Isabel Cuervo Colombia 10 86 0.6× 99 1.8× 45 0.9× 16 0.4× 50 1.6× 47 253
Kirsten van de Groep Netherlands 9 144 1.0× 41 0.7× 23 0.5× 19 0.5× 18 0.6× 13 267
Sanjay Biswas India 11 106 0.8× 61 1.1× 88 1.8× 40 1.0× 39 1.2× 41 330
François Trémolières France 9 135 1.0× 43 0.8× 37 0.7× 53 1.3× 23 0.7× 50 230
Elizabeth Dodds‐Ashley United States 7 106 0.8× 88 1.6× 24 0.5× 12 0.3× 50 1.6× 9 198

Countries citing papers authored by Judith Hackett

Since Specialization
Citations

This map shows the geographic impact of Judith Hackett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Hackett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Hackett more than expected).

Fields of papers citing papers by Judith Hackett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Hackett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Hackett. The network helps show where Judith Hackett may publish in the future.

Co-authorship network of co-authors of Judith Hackett

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Hackett. A scholar is included among the top collaborators of Judith Hackett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Hackett. Judith Hackett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bettiol, Esther, Judith Hackett, & Stéphan Harbarth. (2018). Stimulating Research and Development of New Antibiotics While Ensuring Sustainable Use and Access: Further Insights from the DRIVE-AB Project and Others. The Journal of Law Medicine & Ethics. 46(S1). 5–8. 3 indexed citations
2.
Ruzin, Alexey, Elizabeth Levin-Sparenberg, Xiaohui Jiang, et al.. (2018). Characterization of circulating RSV strains among subjects in the OUTSMART-RSV surveillance program during the 2016-17 winter viral season in the United States. PLoS ONE. 13(7). e0200319–e0200319. 16 indexed citations
3.
Wen, Zehuai, Wei Jia, Huiling Xue, et al.. (2018). Epidemiology, microbiology, and treatment patterns of pediatric patients hospitalized with pneumonia at two hospitals in China: a patient chart review study. Therapeutics and Clinical Risk Management. Volume 14. 501–510. 2 indexed citations
4.
Harbarth, Stephan & Judith Hackett. (2018). Introduction: DRIVE-AB’s definitions and indicators to monitor responsible antibiotic use. Journal of Antimicrobial Chemotherapy. 73(suppl_6). vi2–vi2. 3 indexed citations
5.
Więcek, Witold, Richard Lawson, Betina T. Blak, et al.. (2017). Impact of increased influenza vaccination in 2–3-year-old children on disease burden within the general population: A Bayesian model-based approach. PLoS ONE. 12(12). e0186739–e0186739. 7 indexed citations
6.
Wen, Zehuai, Wei Jia, Huiling Xue, et al.. (2017). Epidemiology, microbiology and treatment implications in adult patients hospitalized with pneumonia in different regions of China: a retrospective study. Journal of Thoracic Disease. 9(10). 3875–3887. 3 indexed citations
7.
Gerlier, Laetitia, Judith Hackett, Richard Lawson, et al.. (2017). Direct and Indirect Protection with Pediatric Quadrivalent Live-Attenuated Influenza Vaccination in Europe Estimated by a Dynamic Transmission Model. Journal of health economics and outcomes research. 5(1). 89–108. 1 indexed citations
8.
Więcek, Witold, Richard Lawson, Betina T. Blak, et al.. (2017). A retrospective observational analysis of post-pandemic influenza-related outcomes in the United Kingdom, 2010–2014. Human Vaccines & Immunotherapeutics. 14(2). 368–377.
9.
Hackett, Judith, Jenna E. Coalson, Xiaohui Jiang, et al.. (2017). Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997–2012. Open Forum Infectious Diseases. 4(1). ofw270–ofw270. 67 indexed citations
10.
Gibson, Edward, et al.. (2016). Economic evaluation of pediatric influenza immunization program compared with other pediatric immunization programs: A systematic review. Human Vaccines & Immunotherapeutics. 12(5). 1202–1216. 10 indexed citations
11.
Gibson, Edward, et al.. (2016). Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles. Journal of Market Access & Health Policy. 4(1). 31205–31205. 6 indexed citations
12.
Karve, Sudeep, et al.. (2016). Ceftaroline fosamil treatment outcomes compared with standard of care among hospitalized patients with complicated skin and soft tissue infections. Journal of Comparative Effectiveness Research. 5(4). 393–405. 6 indexed citations
13.
Kostyanev, Tomislav, Marc J. M. Bonten, Seamus O’Brien, et al.. (2015). The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistance. Journal of Antimicrobial Chemotherapy. 71(2). 290–295. 92 indexed citations
14.
Turner, Ralph M., Bingcao Wu, Kenneth Lawrence, et al.. (2015). Assessment of Outpatient and Inpatient Antibiotic Treatment Patterns and Health Care Costs of Patients with Complicated Urinary Tract Infections. Clinical Therapeutics. 37(9). 2037–2047. 21 indexed citations
15.
Foster, Norman L., et al.. (2014). Justifying reimbursement for Alzheimer's diagnostics and treatments: Seeking alignment on evidence. Alzheimer s & Dementia. 10(4). 503–508. 7 indexed citations
16.
Hackett, Judith. (1987). Issues in Contracting for the Private Operation of Prisons and Jails. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026